Key facts
- PVH Corp. lowered its full-year revenue outlook to flat, causing its shares to fall over 25%.
- Oculis Holding AG's shares fell over 23% after its OCS-01 DME program's Phase 3 trials failed.
- GeneDx Holdings faces a securities class action lawsuit following a 49% stock price drop on May 5, 2026.
- Robbins LLP is urging investors in Commvault Systems securities bought between April 29, 2025, and January 26, 2026, to contact them.
- Rosen Law Firm is reminding Stellantis N.V. investors of a securities fraud lawsuit for purchases made between February 26, 2025, and February 5, 2026.
- Jefferies downgraded Abivax to Hold and cut its price target by 44% after rare cancer cases emerged in a Phase 3 trial.
- Abivax shares fell over 40% in a single session following the trial setback.
- FS KKR Capital Corp. investors have until July 6, 2026, to join a class action lawsuit.
- POET Technologies Inc. investors with losses exceeding $100,000 have until June 29, 2026, to seek lead plaintiff status in a securities fraud investigation.
- Robbins LLP is reminding Badger Meter, Inc. (BMI) investors of a class action deadline of August 3, 2026, for lead plaintiff applications.
- Graphic Packaging Holding Company shareholders have a July 6, 2026 deadline to apply to lead a securities fraud class action lawsuit.
- The Law Offices of Frank R. Cruz is seeking lead plaintiffs for securities fraud class action lawsuits against Phreesia Inc. and Calix, Inc.
A wave of shareholder lawsuits and investigations are targeting numerous companies, alleging securities fraud, breaches of fiduciary duty, and investor harm. PVH Corp. saw its shares plummet over 25% after it lowered its full-year revenue outlook to flat, despite reporting Q1 revenue of $2.025 billion that beat EPS estimates. The Schall Law Firm is investigating potential breaches of fiduciary duty by PVH Corp.'s officers and directors.
Oculis Holding AG is facing an investigation by Levi & Korsinsky after its OCS-01 DME program's Phase 3 DIAMOND trials failed. The company's stock dropped over 23% following allegations that SEC filings misrepresented the program's progress toward an FDA submission. Similarly, GeneDx Holdings is subject to a securities class action lawsuit after its stock price fell 49% on May 5, 2026. This decline is linked to the company's Q1 2026 earnings report and its acquisition of Fabric Genomics.
Several other companies are involved in class action lawsuits. Commvault Systems is facing a class action, with Robbins LLP urging investors who bought securities between April 29, 2025, and January 26, 2026, to contact them. Stellantis N.V. investors who purchased shares between February 26, 2025, and February 5, 2026, are reminded by Rosen Law Firm of a securities fraud lawsuit in which they can lead. FS KKR Capital Corp. is also facing a class action for alleged securities law violations, with a deadline of July 6, 2026, for investors to join. Phreesia Inc. and Calix, Inc. shareholders who suffered losses may have the opportunity to lead securities fraud class action lawsuits, with the Law Offices of Frank R. Cruz seeking lead plaintiffs for both cases. Graphic Packaging Holding Company shareholders who purchased securities between February 4, 2025, and February 2, 2026, may also lead a securities fraud class action, with a July 6, 2026 deadline. POET Technologies Inc. is under investigation by Rosen Law Firm for securities fraud claims against purchasers between April 1, 2026, and April 27, 2026, with investors losing over $100,000 having until June 29, 2026, to seek lead plaintiff status. Badger Meter, Inc. (BMI) investors who purchased stock between April 18, 2024, and April 16, 2026, are reminded by Robbins LLP of a pending class action with a lead plaintiff application deadline of August 3, 2026. Sportradar Group AG shareholders who lost money may lead a securities fraud class action, with Glancy Prongay Wolke & Rotter LLP seeking lead plaintiffs.
Investigations into potential breaches of fiduciary duty are also underway. Via Transportation is being investigated by Ademi LLP for potential securities fraud related to inaccurate statements about its financial statements and business operations. Lucid Group, Inc. and certain officers face a class action lawsuit alleging investor harm, with Bronstein, Gewirtz & Grossman LLC representing investors. Sana Biotechnology, Inc. insiders are being investigated for potential breaches of fiduciary duty, with shareholders invited to discuss their rights. Five9, Inc. insiders are also facing scrutiny for potential breaches of fiduciary duties, with law firms offering consultations on a contingent fee basis. Abivax shares fell over 40% in a single session after Jefferies downgraded the stock to Hold and cut its price target by 44% following the emergence of rare cancer cases in its Phase 3 ulcerative colitis trial.